how can pharmacists approach reimbursement challenges to improve biosimilar use?
Published 5 years ago • 15 plays • Length 0:28Download video MP4
Download video MP3
Similar videos
-
3:03
challenges for payers with costs of biosimilars
-
0:52
how specialty pharmacists can prepare patients to switch to biosimilars
-
0:41
what steps need to be taken to increase prescriber uptake of biosimilars?
-
3:02
biosimilar medications — what patients need to know
-
1:29
biosimilars poised to impact specialty pharmacy
-
1:01:14
ep 88 biosimilars - interchangeability & switching 2023
-
6:07
manufacturing of biologics
-
3:33
biosimilars: manufacturing and inherent variation
-
1:26
how will payers manage biosimilars?
-
11:15
pricing of biosimilars with biologics and other biosimilars
-
1:00
the long-term impact of biosimilars on specialty pharmacy
-
1:27
how do biosimilars differ from generics?
-
1:27
what is the future of biosimilars?
-
5:44
role of biosimilars in the specialty marketplace
-
1:02:17
integrating insulin biosimilars into clinical practice: new pathways and new challenges
-
2:54
switching from biologics to biosimilars: 4 tips for talking to your doctor | goodrx
-
1:14
what has been the manufacturer response to biosimilars?
-
4:12
the basics of biosimilars
-
3:04
how biosimilar drug approvals provide opportunities for pharmacists
-
1:37
biosimilar medications – what health care providers need to know
-
0:58
biosimilars in specialty pharmacy
-
1:00:54
biosimilar laws | sonia oskouei, pharmd, vp biosimilars at cardinal health